IP Library › Granted Patent US 8,288,557
Granted Patent B2
US 8,288,557 · App. 11/632,895 · Granted Oct 16, 2012

Bivalent linkers and conjugates thereof

Assignee: Endocyte, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,288,557
App. No.
11/632,895
Granted
Oct 16, 2012
Kind
B2
Abstract

Bivalent linkers derived from compounds of formulae (V), (VI), and (VII), where X 1 and X 2 are leaving groups and the other variables are as defined in the claims, to be included in or for preparing vitamin, drug, diagnostic agent, and/or imaging agent conjugates are described.

Claims (13)

1. A compound of the formula

wherein

X 1 is a leaving group displaceable by a nucleophile;

Q is

where R a and R b are each independently selected from the group consisting of hydrogen and alkyl; or R a and R b are taken together with the attached carbon atom to form a carbocyclic ring; n is an integer from 1 to about 4; and * represents the point of attachment; and

X 2 is optionally substituted heteroaryloxy.

2. The compound of claim 1 wherein n is 1.

3. The compound of claim 1 wherein R a and R b are selected from the group consisting of hydrogen and lower alkyl.

4. The compound of claim 1 wherein R a and R b are each hydrogen.

5. The compound of claim 1 wherein R a and R b are taken together with the attached carbon atom to form a carbocyclic ring.

6. The compound of claim 1 wherein R a and R b are taken together with the attached carbon atom to form cyclopropyl.

7. The compound of claim 1 wherein the X 1 is optionally substituted heteroarylthio.

8. The compound of claim 1 wherein the X 2 is optionally substituted benzotriazolyloxy.

Continuity (2)
Provisional Application 60590580 · Jul 23, 2004
Related Publication 20090203889A1 · Aug 13, 2009